NCT06988059View on ClinicalTrials.gov

A Study of CT0596 in Plasma Cell Leukemia

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

June 25, 2025

Primary Completion Date

January 3, 2027

Study Completion Date

December 31, 2027

Conditions
Plasma Cell Leukemia
Interventions
DRUG

CAR-T cells Infusion chimeric antigen receptor T cells

CAR-T cells Infusion

Trial Locations (1)

Unknown

RECRUITING

Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences, Tianjin

Sponsors
All Listed Sponsors
collaborator

CARsgen Therapeutics Co., Ltd.

INDUSTRY

lead

Institute of Hematology & Blood Diseases Hospital, China

OTHER